08.05.2020 With immediate effect: 3 million proven antibody tests for SARS-CoV-2 and mastermix ready-to use PCR tests. 17 million more antibody tests available.
25.3.2020 At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply shortages for our medicinal products because of the coronavirus COVID-19. We support this by a prevention program and our purchasing and production strategy: medac has prepared itself carefully to protect employees and supply […]
Medac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Highly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS and AML Click here to view full Press release
/wp-content/uploads/2017/03/logoBlueNew3.png00Admin medac/wp-content/uploads/2017/03/logoBlueNew3.pngAdmin medac2018-03-26 08:56:282020-07-02 17:07:01Press release – Results of phase III study with Treosulfan, EMA approval pending
Tämä sivusto käyttää evästeitä. Jatkaaksesi sivustomme käyttöä, sinun tulee hyväksyä evästeet.
Press Release – medac Diagnostics: a complete package for COVID-19 testing
/in kategorioimaton /by Super Ezy08.05.2020 With immediate effect: 3 million proven antibody tests for SARS-CoV-2 and mastermix ready-to use PCR tests. 17 million more antibody tests available.
Press Release – medac Diagnostics Portfolio
/in kategorioimaton /by Super Ezy08.05.2020 With immediate effect: medac´s proven methods for SARS-CoV-2 testing for the German-speaking world
Medac statement regarding the coronavirus COVID-19:
/in kategorioimaton /by Super Ezy25.3.2020 At this moment in time, and after consultation of the competent authorities, we do not foresee any interruptions in production and therefore no supply shortages for our medicinal products because of the coronavirus COVID-19. We support this by a prevention program and our purchasing and production strategy: medac has prepared itself carefully to protect employees and supply […]
Press release – First marketing authorisation worldwide for methotrexate in moderate psoriasis
/in kategorioimaton /by Admin medacMedac’s marketing authorisation extension gives many patients with psoriasis access to guidelines-based MTX therapy for the first time. Click here to view full Press release
Press release – Results of phase III study with Treosulfan, EMA approval pending
/in kategorioimaton /by Admin medacHighly effective with reduced toxicity – Treosulfan-based regimen is a promising new conditioning therapy for MDS and AML Click here to view full Press release